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Abstract
Background:
Multiple myeloma (MM) presents with spinal lesions in 60% of cases. The combination of osteolytic
lesions with multifactorial osteopenia raises specific surgical treatment challenges. Minimally invasive
spine surgery (MISS) could be a potential option for MM spinal lesions treatment.
Objective:
The objective of this study is to evaluate MISS techniques to treat patients presenting with spine fractures
due to MM
Methods:
Retrospective analysis of consecutive patients with histology-proven pathological fractures caused by MM
treated with MISS between 2009 and 2018. We collected the data from the clinical records on
epidemiology, topography of spine lesions, surgical techniques, blood loss, operation time, complications,
mean in-hospital time, and clinical evolution.
Results:
Twenty-one patients were studied – 13 males and 8 females, with a mean age of 64 years (range 43–83).
Mean preoperative spinal instability neoplastic score was 9.8 ± 6 (range 5–16). All cases had a
thoracolumbar location – 15 patients underwent kyphoplasty (KP) or vertebroplasty (VP) and 6 were
treated with other more complex procedures. All patients had a reduction of pain and/or analgesic load.
Vertebral body height increased by a mean of 2.9 mm after VP/KP. Mean hospital stay was 1.3 days for
KP/VP and 5.0 days for other MISS procedures. Three patients had complications.
Conclusions:
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The heterogeneity of techniques used reflected the variety of spine involvement by MM. KP and VP led to
shorter hospital stays and less complications, being adequate for lesions without major instability. More
complex MISS techniques offer an effective treatment with short delay for starting MM adjuvant
treatment.
Keywords: Kyphoplasty, minimally invasive surgical surgery, multiple myeloma, spine fracture, tumor
percutaneous pedicle screws stabilization
INTRODUCTION
Multiple myeloma (MM) is a clonal, malignant proliferation of plasmocytes,[1] representing 1% of all
tumors and 13% of all hematological tumors.[1] Bone involvement is common, affecting 70% of patients
with MM.[2,3] Spine lesions, which are present in 60% of MM patients,[4] cause wedge fractures with
significant axial pain, vertebral collapse, kyphotic deformity, myelopathy, and radiculopathy.[2,5] Eighty
percent of fractures occur in T6-L4 segment with 50% in T11-L1.[4]
Besides osteolytic lesions, osteopenia is another important feature in MM pathophysiology.[6] It affects
mainly vertebral bodies and less frequently the pedicle or transverse/spinous processes. It is important to
underline that steroids and radiotherapy can also aggravate bone osteopenia,[7] raising further difficulties
to the classical “open” surgical strategy.
The treatment for MM is essentially medical-chemotherapy, bone protection with bisphosphonates, and
radiotherapy.[8] Surgery is indicated to solve some of the associated complications – spinal instability,
[9,10] neurological deficits due to compressive lesions, and pain refractory to the best medical treatment.
[4,11,12] The solitary bone plasmacytoma (SBP), a single lytic lesion without bone marrow plasmacytosis,
[1,8] is a good indication for surgery with curative goal.
Therefore, the benefits associated with minimally invasive spine surgery (MISS) can emerge as a sound
option in MM patients, affected simultaneously by osteolysis and osteopenia. Even if it requires a
significant amount of surgical expertise, MISS can provide a low approach-related morbidity solution that
may accelerate the start of adjuvant systemic therapies.[13,14,15] Many studies highlight the role of
cement augmented techniques;[16,17,18] however, mini-open decompression techniques and percutaneous
posterior transpedicular fixation have not yet been validated to treat MM patients. In this study, we review




We retrospectively reviewed all patients who underwent surgical treatment for spine MM with MISS
techniques at the Neurosurgery Department of the Centro Hospitalar de Vila Nova de Gaia/Espinho and
Hospital Lusíadas Porto, from 2009 to 2018. Only patients with histology-proven spine disease were
included. We collected retrospectively the information from the clinical databases available (SAM clinical
software, SAM , ACSS – Lisbon, Portugal. SECTRA , SECTRA AB – Linkoping, Sweden, and the
SECTRA imaging software).
Variables
Data collected included demographic variables (age and gender), number and topography of lesions,
preoperative Spinal Instability Neoplastic Score (SINS), surgical technique, blood loss, duration of
surgery, vertebral body height restoration, complications, re-operations, duration of hospital stay, time to
start adjuvant therapies, duration of clinical follow-up, and clinical outcomes (Karnofsky Performance
Score [KPS]).
RESULTS
The general features of our patients are displayed in Table 1.
® ®
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We included in the study 21 consecutive patients with histological diagnosis for MM/SBP, for the period of
2009-2018. The mean follow-up duration was 11.1 ± 9.18 months (5-24 months). The mean age at surgery
was 64 years (43-83 years). Thirteen patients were male (62%), and eight were female (38%).
In total, 42 index levels were treated in the 21 patients – 23 in thoracic segment and 19 in lumbar segment
[Figure 1]. All patients presenting with spine fractures, regardless of previous diagnosis, had bone samples
taken for histological analysis, which allowed “de novo” diagnosis of MM or SBP in 8/21 patients (38%).
Mean preoperative SINS was 9.8 (range 6-16). Patients submitted to kyphoplasty (KP) or vertebroplasty
(VP) scored a mean of 8.8 (range 6–12), whereas those operated with other MISS techniques scored a
mean of 12.3 on SINS (range 7–16).
Fifteen patients (71%) were treated with either KP or VP, whereas six patients (29%) were submitted to
more complex MISS procedures. VP/KP was performed through a percutaneous transpedicular approach,
followed either by direct injection of polymethylmethacrylate (PMMA), balloon dilation before PMMA
injection, or placement of a titanium stent (OsseoFix®, Alphatec Spine, CA, USA). Vertebral body height
increased by a mean of 2.9 ± 5.3 mm (range-3.6–16.8 mm) with these techniques.
In six patients (29%), due to major instability or because required bony decompressive procedures would
putatively threaten the spine stability, we performed percutaneous pedicle screw fixations, eventually
supplemented by decompressive procedures:
One patient underwent stand-alone pedicle screw fixation – due to a significant breach in the
posterior wall, it was decided not to perform KP/VP;
In one case, VP was performed in combination with posterior fixation to provide anterior column
support in a poor bone density spine;
Three patients were submitted to a paramedian mini-open tumor resection and neural
decompression, supplemented with percutaneous pedicle screw fixation;
One case of vertebral body reconstruction with an expandable cylinder inserted through a mini-open
retractor after tumor removal.
Mean operative time was 49.3 ± 14.4 min for KP/VP and 152.0 ± 36.9 min for the other techniques.
Patients submitted to KP/VP presented with vestigial blood loss (defined as estimated <20 ml), whereas
other procedures lead to a mean blood loss of 141.2 ± 94.3 ml. The mean in-hospital stay was 1.13 ± 0.34
days for cement or stent-augmented techniques (n = 15), comparing to 5.0 ± 2.3 days for the patients
submitted to more complex MISS techniques (n = 6). In two patients, a longer hospital stay was explained
by more aggressive systemic disease presentation.
All patients, whether subjected to KP/VP or other procedures, had resolution, or significant reduction of
pain and analgesic load reduction, from the immediate postoperative period onwards. Eight patients
presented initially with neurological deficits-6 of these (75%) were treated with more complex MISS
procedures. Two did not improve their neurological status after the procedures, one from each group.
Adjuvant therapies were implemented 3.8 ± 2.1 weeks after surgery [Table 2]. Worth of notice is the fact
that four patients of the KP/VP cohort did not interrupt the adjuvant schemes, being treated as planned.
Three patients developed complications: One patient presented with a urinary tract infection; another
patient had a small lateral PMMA leak, without any clinical consequences; one case of CSF leak that did
not require surgery, but prolonged the duration of hospital stay (an outlayer). There were neither cases of
recurrence at levels previously treated nor cases of instrumentation failure.
Patient's outcome was heavily influenced by the systemic disease effects of progressive MM. Nine patients
were alive at last follow-up, 8 of them with a KPS >70 – the remaining patient had significant disability
due to concomitant severe Parkinson's Disease. Twelve patients died as a consequence of MM or related
complications, nevertheless surviving a mean of 14.2 ± 7.6 months after surgery.
Illustrative caseF
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Case 7 describes a 47-year-old female with familiar spastic paraparesis but capable of independent
ambulation, who presented with worsening of paraparesis (strength I/V) and dorsal pain (visual analogue
scale [VAS] 7) in 2012. Dorsal computed tomography (CT) revealed a collapse of D10 due to a lytic lesion
of unknown origin with evidence of invasion of the posterior arch and anterolisthesis of D9, causing cord
compression, which was confirmed with magnetic resonance imaging [Figure 2]. Similar lytic lesions were
described in the adjacent vertebra, but without neurological compromise. The patient scored 14 in the
SINS. A D10 corpectomy and insertion of an expandable cylinder was performed through a paramedian
mini-open technique supplemented with a percutaneous pedicle fixation from D8 to D12, two-levels above
and below the lesion. Histological examination characterized the lytic lesion as a “de novo” MM.
Postoperative CT confirmed both the appropriate surgical decompression and correct the placement of the
instrumentation [Figure 3]. After the procedure, the patient had a significant improvement in pain scores
(VAS 2) when she was discharged. At 6 months of follow-up and rehabilitation, her paraparesis had
stabilized at a level strength of III/V.
DISCUSSION
Our clinical study demonstrates the high degree of complexity when managing MM patients with spine
lesions. The first constraint is diagnostic, as the distribution of spine levels affected by MM fractures
overlap with that of the less benign osteoporotic fractures,[19] which are far more common. For this
reason, our protocol of cement-augmented procedures always includes an initial bone biopsy. Accordingly,
we found a high number of primary “de novo” diagnosis, which represent 38% of our cohort of patients.
Togawa et al. reported 2.8% of new diagnosis of plasma cells dyscrasias in their series.[20] Muijs et al.
similarly found 3.8% of new neoplasms, including two cases of previously undiagnosed MM.[21] Both
authors advocate that in every vertebral fracture treated surgically a diagnostic biopsy should be done,
which is in line with our institutional protocol.[20,21]
Moreover, a significant proportion of MM patients present with spine disease in the thoracolumbar
junction,[19,22] with 50% of lesions concentrated in T11-L1 region. This is a transition zone between a
low and high mobile spine, subject to a higher degree of biomechanical stress, leading to an increased
incidence of vertebral fractures at these levels. The frequency of fractures in MM is further amplified by
the associated poor bone quality due to steroids use and to calcium metabolism impairment, a relevant
feature in the pathogenesis of MM fractures.[22] Thus, in comparison to spine metastatic disease, MM
raises additional surgical challenges related to osteopenia, which has a strong impact in the incidence of
complications. Zadnik et al.[11] described 14 complications in their cohort of 31 patients, including four
cases of instrumentation failure – either rod fracture or loosening of screws. Guzik[23] reports eight
complication in 129: 3 patients suffered from impaired wound healing and 2 patients had their
instrumentation revised. In our cohort, by using only MISS techniques, no cases of hardware failure were
noticed, in relation to the use of long construct or anterior column support with cement or expandable
cylinder. The MISS techniques leave intact the posterior ligaments and muscles, namely multifidus
muscle, the largest force generating capacity muscle in lumbar spine, which is designed for stability,
especially in flexion. This is of paramount importance to preserve spine stability after surgery to reduce
hardware complications in a rather osteoporotic spine.
Regarding the KPS, Guzik[23] reported that the mean KPS for patients with spine tumors (not only MM)
treated with VP increased from 60 ± 7.9 to 80 ± 7.9. They reported similar progression for the stabilization
cohort, though their group included MISS and non-MISS patients (54 ± 9.8–59 ± 12.2). In our series of
enrolling only MM patients, all had favorable outcomes facilitated by the use of MISS techniques, in terms
of pain relief, spine stability, and functional status (8 patients out of 9 survivors at last follow-up with KPS
> 70).
MISS literature on spine tumors, mostly regarding metastatic disease, offers evidence of less blood loss,
[24,25] less in-hospital stay[25] and better functional status for these patients,[24,26] by reducing
approach-related morbidity without sacrificing the goal of the procedures.[27] Although no previous
studies focused specifically on MISS in MM disease, our study clearly demonstrates that similar outcomes
apply to these patients.F
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The patients in our cohort started adjuvant therapies on average 3.8 weeks after surgery. Of notice, four
patients submitted to cement augmentation did not pause chemotherapy regimens already under way,
having been operated between cycles with no subsequent adverse events. MISS techniques provided a
quick wound healing due to smaller skins incisions and less soft-tissue damage, in rather catabolic patients
due to adjuvant therapies, without any case of wound dehiscence or infection. This is essential to start or
resume, in a timely mode, the adjuvant therapy for MM, which is crucial for disease control.[8,28]
For patients presenting with spinal fractures without instability or spinal cord compression, KP and VP are
very effective in treating pain otherwise refractory to medical treatment. KP/VP showed no clinically
relevant complications and is associated with a shorter hospitalization time (1.3 ± 0.34 days). Simony et al.
[29] reported in their cohort a significant reduction of VAS after VP-7.6-3.2, at 3 months of follow-up.
Several authors described similar results in their studies regarding pain control.[2,14,16,30] Furthermore,
these interventions are effective at restoring vertebral body height, as our series demonstrated (Δheight of
2.9 ± 5. 3 mm), with the potential to positively influence sagittal balance. Teng et al.[31] and Dublin et al.
[32] reported on the efficacy of cement augmentation on height restoration and overall sagittal balance
(29% height restauration for the anterior border and mean reduction in kyphosis of 4.3°[31]).
Finally, the surgical strategy should be tailored to individual patients, according to the sagittal and axial
location of the MM lesions, the occurrence of instability and spinal cord compression. The SINS score was
important in the decision-making regarding the technique choice, especially in assessing the need for
additional pedicle screw stabilization and anterior column support.[33] Pennington et al.[25] report a good
intraobserver and interobserver reliability of the SINS score in their meta-analysis, especially among spine
surgeons. In our series, patients submitted to cement or stent augmentation scored lower in the SINS score
than those submitted to more complex techniques (mean of 8.8 ± 1.7 vs. 12.3 ± 2.6). Robust
instrumentation should be performed in patients with instability to provide posterior elements and vertebral
body support and thus avoid hardware complications. A more aggressive surgical resection is indicated in
cases of spinal cord compression with neurological translation or in case of solitary bone plasmocytoma
with a curative intention. Both Xie et al. and Huang et al. reported that gross total resection reduced local
recurrence and progression to MM.[7,34]
There are some limitations in our study that need to be mentioned. The retrospective nature of the study
and the lack of control group submitted to non-MISS techniques limit the strength of the conclusions.
Although the number of patients treated with MISS techniques is small, this study includes only MM
patients, which is a unique feature in the related literature. Accordingly, the study provides new
information on how to treat spine lesions MM-related according to MISS principles, leading to less blood
loss, less operating time hospital stay, less analgesic use, less complications, and less hardware failure
because of minimal soft-tissue damage in a peculiar pathology that combines osteolytic lesion with
osteopenia.
CONCLUSIONS
Our experience favors the conclusion that MISS techniques applied to MM spine lesions contribute to
faster recovery, allow quick starting of adjuvant therapy and reduced approach-related morbidity and
hardware failure, due to muscle and ligament sparing, in a pathology that combines osteolytic lesions with
osteopenia.
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Table 1
Summary of clinical features of patients enrolled in our series described in a chronological
sequence
Age Gender Levels SINS Approach HS OR T BL Complications
2009
 Case 1 76 Male T8; T9 12 VP/KP 1 40 Vestigial None
 Case 2 70 Female T6; T8; L4 10 VP/KP 2 50 Vestigial None
 Case 3 58 Male T5; T9 10 VP/KP 1 65 Vestigial PMMA leak
 Case 4 73 Female L1 7 VP/KP 1 20 Vestigial None
2012
 Case 5 63 Male L1; L3 10 VP/KP 2 55 Vestigial None
 Case 6 67 Male L2; L3; L4 9 VP/KP 1 70 Vestigial None
2013
 Case 7 47 Female T10 14 Combined 8 170 250 CSF leak
 Case 8 58 Male T12; L3; L5 11 VP/KP 1 65 Vestigial None
 Case 9 50 Female L1; L4 6 VP/KP 1 35 Vestigial None
 Case 10 66 Male T10 13 Posterior 7 80 50 Urinary infection
2015
 Case 11 80 Male T5 16 Posterior 5 170 150 None
 Case 12 43 Female L1 10 Posterior 5 110 50 None
 Case 13 49 Female T4 12 Posterior 2 150 150 None
2016
 Case 14 61 Male T11; T12 10 VP/KP 1 50 Vestigial None
 Case 15 73 Male T6 9 Posterior 3 160 200 None
2017
 Case 16 83 Male L2; L4 6 VP/KP 1 45 Vestigial None
 Case 18 54 Female T9; T11; T12; L1 9 VP/KP 1 50 Vestigial None
 Case 17 77 Female T9 9 VP/KP 1 35 Vestigial None
 Case 18 76 Male T6; T11; L1 7 VP/KP 1 55 Vestigial None
2018
 Case 19 77 Male L1, L2 9 VP/KP 1 40 Vestigial None
 Case 20 52 Male T7; T8; T9; T12; L1 11 VP/KP 1 65 Vestigial None
Open in a separate window
PMMA - Polymethyl methacrylate, HS - Hospital stay in days, OR T - Operation room time in minutes, BL - Blood
loss in ml. vestigial <20 ml, SINS - Spinal instability neoplastic score, KP - Kyphoplasty, VP - Vertebroplasty, CSF -
Cerebrospinal fluid
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Figure 1
Histogram showing the distribution of the spine levels that were operated (n = 42)
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Table 2
Clinical outcomes associated with the different techniques
Outcomes
ΔKPS RT/CT (weeks) Mean survival (m)
KP/VP 10.0±9.3 3.3±1.7 30.4±29.5
MIS fixation/decompression 23.3±10.3 4.0±2.3 34.2±21.4
KPS - Karnofsky performance score, RT/CT - Radiotherapy/chemotherapy in weeks, KP - Kyphoplasty, VP -
Vertebroplasty, MIS - Minimally invasive surgery, Mean survival in months
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Figure 2
Thoracolumbar computed tomography and magnetic resonance imaging (T2W1 and short-time inversion
recovery) showing extensive destruction of D10 with significant retropulsion in the spinal canal, cord
compression and kyphotic deformity
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Figure 3
Postoperative computed tomography scans: At day 8 (a) and 2 years after surgery (b and c). Note the long-
standing release of spinal cord compression and the significant correction of the kyphotic deformity. Significant
decompression was achieved (D). The long construct 2-levels above and below the multiple myeloma lesion, the
optimal convergence of percutaneous pedicle screws and the anterior column support afforded by the cylinder
contributed to the long-term stability of the hardware construct
Articles from Journal of Craniovertebral Junction & Spine are provided here courtesy of Wolters Kluwer --
Medknow Publications
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